跳至主要内容
临床试验/IRCT20180103038196N4
IRCT20180103038196N4已完成3 期

Evaluation of omega-3 supplementation intake on the risk of preeclampsia in nulliparous pregnant women

Gorgan University of Medical Sciences0 个研究点目标入组 122 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
122

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 40 years(—)
性别
Female

入选标准

  • nulliparous Pregnant women with 14 to 18 weeks gestational age
  • Satisfaction to participate in the study
  • Women without a high risk of preeclampsia (age under 20 and over 40 years, history of preeclampsia in a previous pregnancy or in the family, twins pregnancy, body mass index equal or greater than 29, kidney disease and hypertension )
  • Do not use calcium, aspirin, anticoagulants and insulin
  • No history of allergy to omega-3
  • 20 to 40 years old

排除标准

  • Unwillingness to cooperate
  • Forced to use aspirin, calcium and heparin during the study
  • Not being able to continue taking medication due to digestive problems or because of an allergic reaction
  • Women with a high risk of preeclampsia

研究者

发起方
Gorgan University of Medical Sciences

相似试验